- Opin vísindi
- →
- IRIS
- →
- IRIS
- →
- Browsing IRIS by Subject
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing IRIS by Subject "Lyfjafræðingar"
Now showing items 1-7 of 7
-
(2024-03-28)OBJECTIVES: To determine the prevalence and incidence of polypharmacy/hyperpolypharmacy and which medications are most prescribed to patients with varying burden of polypharmacy. DESIGN: Retrospective, population-based cohort study. SETTING: Iceland. ... -
(2023-01-01)OBJECTIVES: To evaluate the access to comprehensive diagnostics and novel antituberculosis medicines in European countries. METHODS: We investigated the access to genotypic and phenotypic Mycobacterium tuberculosis drug susceptibility testing and the ...
-
(2021-03)TILGANGUR Langtímaárangur efnaskiptaaðgerða hjá einstaklingum með offitu er almennt góður, með tilliti til þyngdartaps, fylgisjúkdóma offitu og lífsgæða. Hins vegar geta aðgerðirnar aukið líkur á næringarefnaskorti. Markmið rannsóknarinnar var að kanna ...
-
(2022-06-16)Background: Cardiomyopathy is a known complication of organic acidemias but generally thought to be secondary to poor metabolic control. Methods: Our patient was found through biochemical testing and Sanger sequencing to harbor an Icelandic founder ...
-
(2023-05-05)Background: The aim of this study was to determine the prevalence of preoperative polypharmacy and the incidence of postoperative polypharmacy/hyper-polypharmacy in surgical patients and their association with adverse outcomes. Methods: This was a ...
-
(2023-05-05)Ágrip INNGANGUR Notkun prótónpumpuhemla (PPH) hefur aukist á undanförnum áratugum. Hluti sjúklinga er á lyfjunum án ábendingar. Mögulegt er að ný notkun hefjist í kjölfar skurðaðgerða. Markmið rannsóknarinnar var að skoða nýgengi notkunar PPH í kjölfar ...
-
(2023-10-01)BackgroundEuropean-specific policies for tuberculosis (TB) elimination require identification of key populations that benefit from TB screening.AimWe aimed to identify groups of foreign-born individuals residing in European countries that benefit most ...
Now showing items 1-7 of 7